Peroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription
factor that belongs to the steroid hormone receptor superfamily. PPARα is expressed …

Agonists directed against the α and γ isoforms of the peroxisome proliferator-activated
receptors (PPARs) have become important for the respective treatment of …

Предлагаемая читателю монография–одна из первых попыток систематизации
накопленной к настоящему времени информации в области молекулярной генетики …

Background Studies in mice have shown that PPARα is an important regulator of hepatic
lipid metabolism and the acute phase response. However, little information is available on …

The peroxisome proliferator-activated receptors (PPAR) belong to the nuclear hormone
receptor superfamily and there are three primary subtypes, PPARα, β, and γ. These …

Peroxisome proliferator-activated receptor-α (PPARα) agonists such as fenofibrate are used
to treat dyslipidemia. Although fenofibrate is considered safe in humans, it is known to cause …

Rosiglitazone is a commonly prescribed insulin‐sensitizing drug with a selective agonistic
activity on the peroxisome proliferator‐activated receptor‐gamma (PPAR‐γ). PPAR‐γ can …

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear
transcription factors that belong to the nuclear receptor superfamily. Three isoforms of PPAR …

PPARδ (peroxisome proliferator-activated receptor δ) is a regulator of lipid metabolism and
has been shown to induce fatty acid oxidation (FAO). PPARδ transgenic and knock-out mice …

Peroxisome proliferator-activated receptor (PPAR)-γ is reduced in pulmonary arteries (PAs)
of patients with PA hypertension (PAH), and we reported that deletion of PPARγ in smooth …